| Combined | PPMI | WUSTL | |||
---|---|---|---|---|---|---|
 | Controls (432) | Cases (829) | Controls (139) | Cases (336) | Controls (293) | Cases (493) |
Females, n (%) | 197 (45.60) | 278 (33.53) | 94 (67.63) | 116 (34.52) | 166 (56.66) | 162 (32.86) |
Age at Onset (years) | – | 60.99 | – | 62.50 | – | 61.00 |
Age at Last Assessment (years) | 63.60 | 64.70 | 61.30 | 61.74 | 64.86 | 67.40 |
Age at Lumbar Puncture (years) | 62.73 | 63.61 | 63.04 | 63.07 | 60.60 | 65.65 |
Family History of PD, n (%) | 11 (2.55) | 211 (25.45) | 8 (5.76) | 79 (23.51) | 3 (1.02) | 132 (26.77) |
 | Controls (155) | Cases (422) | Controls (135) | Cases (334) | Controls (20) | Cases (88) |
α-syn (pg/mL ± SD) | 829.30 ± 853.67 | 1800.90 ± 706.85 | 2173.5 ± 800.80 | 1865 ± 717.65 | 1725 ± 453.77 | 1556.20 ± 608.45 |
Aβ1–42 (pg/mL ± SD) | −0.004 ± 0.12a | −0.013 ± 0.12a | 378.40 ± 104.37 | 377.30 ± 99.63 | 926.40 ± 148.02 | 808.30 ± 215.07 |
t-tau (pg/mL ± SD) | 0.021 ± 0.18a | −0.038 ± 0.16a | 53.95 ± 22.90 | 46.18 ± 18.77 | 250.40 ± 113.58 | 222.87 ± 85.34 |
p-tau (pg/mL ± SD) | −0.004 ± 0.21a | −0.057 ± 0.21a | 17.49 ± 9.49 | 15.95 ± 9.40 | 47.00 ± 17.51 | 37.19 ± 13.23 |